NCT05555381 (Young-D) is a NA clinical trial of young-D program in Early Onset Dementia, sponsored by KU Leuven.

Who is sponsoring NCT05555381?

NCT05555381 is sponsored by KU Leuven.

What drugs are being tested in NCT05555381?

Interventions in NCT05555381: young-D program.

What condition does NCT05555381 study?

NCT05555381 studies Early Onset Dementia, Young Onset Dementia, Stress, Distress, Emotional, Anxiety, Sleep Problem, Sleep, Insomnia.

Is NCT05555381 still recruiting?

NCT05555381 is currently status unknown. Last updated 26 September 2022.

Last reviewed 2022-09-26 · How we verify

NCT05555381: Young-D

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Anxiety, Stress and Sleep Problems in People With Early Onset Dementia

Status unknown NA Last updated 26 September 2022

What this trial tests

NA trial testing young-D program in Early Onset Dementia in 60 participants. Status unknown.

Timeline

1 November 2022

Primary endpoint
30 September 2024

30 September 2025

Quick facts

Lead sponsor	KU Leuven
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	60
Start date	1 November 2022
Primary completion	30 September 2024
Estimated completion	30 September 2025
Sites	2 locations across Belgium

Drugs / interventions tested

young-D program

Conditions studied

Early Onset Dementia — all drugs for Early Onset Dementia →
Young Onset Dementia — all drugs for Young Onset Dementia →
Stress — all drugs for Stress →
Distress, Emotional — all drugs for Distress, Emotional →

Sponsor

KU Leuven — full company profile →

Who can join

Eligibility, any sex, with Early Onset Dementia or Young Onset Dementia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to * detect and assess needs of people with early onset dementia regarding anxiety, stress and sleep * implement a 6 week intervention pilot study in wich weekly (hourly) sessions are implemented in day care settings in order to decrease anxiety, stress and sleep problems in people with early onset dementia

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer's disease.
Morrone CD, Raghuraman R, Hussaini SA, Yu WH. · · 2023 · cited 40× · PMID 37085942 · DOI 10.1186/s13024-023-00617-4

Verify or expand the search:

Other KU Leuven trials

Trials by the same sponsor.

NCT07508696 — Cerebellar Research in Ultrasound Stimulation · NA · not yet recruiting
NCT07476716 — Peer-modeled Intervention · NA · not yet recruiting
NCT07534384 — Automated CPET Interpretation: International Validation Study · not yet recruiting
NCT07419555 — Belgian Lung Function Study · recruiting
NCT07295600 — Postprandial Effect of Isocaloric Challenge Meals Enriched With Indigenous Fruits and Vegetables on Glucose Metabolism i · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05555381 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by KU Leuven
Last refreshed: 26 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05555381.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing